Management of Osteoporosis in the Era of COVID-19

Osteoporosis is a chronic illness characterised by weakened bones and an increased risk of fracture. Osteoporosis is a chronic disorder that usually need long-term medical treatment to prevent further bone loss, skeletal integrity damage, and fractures. The fact that rapid termination of some medications is linked to an elevated risk of injury further complicates the situation. In this setting, the COVID-19 pandemic has caused extraordinary disruption in the delivery of health care throughout the world, including near-universal social distancing restrictions. In this Perspective, we present information on the general management of osteoporosis patients in the COVID-19 period, when available, and clinical recommendations based mostly on expert opinion when data are lacking. The transition from parenteral osteoporosis treatments is given special attention. These suggestions are envisaged to be used to safely guide care for osteoporosis patients until a restoration to normal clinical care standards is possible.

 

    Related Conference of Management of Osteoporosis in the Era of COVID-19

    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    Management of Osteoporosis in the Era of COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in